Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

The S&P 500 ended higher on Thursday, springing back from early losses as investors concerned about AI stocks shifted into ...

The apparent contradiction can be explained by how the index is constructed and the different periods being measured.

The S&P 500 recouped most of its early losses to trade near flat on Thursday as a selloff in AI stocks eased and investors ...

Eli Lilly and Company (NYSE:LLY) has delivered the kind of growth that helps explain why investors are willing to pay a ...

Eli Lilly's share price climb has decelerated in 2026.

Eli Lilly and Company (NYSE:LLY) has returned 36.37% over the last six months, as of October 15. This compares to a 21.5% ...

Eli Lilly spent most of its 150-year history as a quiet insulin maker before a single drug reshuffled the entire obesity ...

Moderna ( MRNA) rose roughly 5% and Eli Lilly ( LLY) added nearly 3% to rank among the day’s best-performing stocks in the S&P 500. Drugmakers Amgen ( AMGN) and Johnson & Johnson ( JNJ) also climbed, ...

Eli Lilly shares reportedly jump 5.45% to a record $1,307.91 as healthcare stocks rally, supported by demand for obesity ...